Sunkyu Han
KAIST 화학과 · 약학
한순규 교수의 연구실은 자연물 합성과 생합성 유사 전략을 중심으로, 복잡한 생체 활성 자연물의 효율적이고 에너지 절약형 합성을 목표로 합니다. 특히 비대칭 산화 및 구조 재편을 통한 생합성 유사 전환 전략을 개발하여, 트리고노리미인 알칼로이드와 같은 복합 구조를 정밀하게 합성하고 있으며, 이는 생물학적 기전을 모방한 촉매 설계와도 연결됩니다. 또한, 고도로 기능화된 자연물 전구체를 대상으로 하는 새로운 고리 열림 기반 기능화 반응을 개발하여 합성 루트를 극적으로 단순화하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
The concise and enantioselective total syntheses of (-)-trigonoliimines A, B, and C are described. Our unified strategy to all three natural products is based on asymmetric oxidation and reorganization of a single bistryptamine, a sequence of transformations with possible biogenetic relevance. We revise the absolute stereochemistry of (-)-trigonoliimines A, B, and C.
We report three distinct, peptide-based catalysts that enable site-selective phosphorylation of three distinct hydroxyl groups within the complex glycopeptide antibiotic teicoplanin A2-2. Two of the catalysts are based on a design that capitalizes on a catalyst-substrate interaction that mimics the biological mechanism of action for teicoplanin. These catalysts are based on a DXaa-DXaa peptide motif that is known to target the teicoplanin structure in a specific manner. The third was identified
A full account of our concise and enantioselective total syntheses of all known (-)-trigonoliimine alkaloids is described. Our retrobiosynthetic analysis of these natural products enabled identification of a single bistryptamine precursor as a precursor to all known trigonoliimines through a sequence of transformations involving asymmetric oxidation and reorganization. Our enantioselective syntheses of these alkaloids enabled the revision of the absolute stereochemistry of (-)-trigonoliimines A,
Abstract Natural product synthesis has lain at the heart of organic chemistry. Complex structures of natural products have inspired chemists to develop new methods and strategies. The utility and robustness of newly developed methodologies have been tested by their application into total synthesis. With the necessity to establish a solid health‐related and biomedical Korean industrial ecosystem, a historically belittled sector when compared to well‐invested manufacturing and electronics industri
Biosynthetic processes often involve reorganization of one family of natural products to another. Chemical emulation of nature's rearrangement-based structural diversification strategy would enable the conversion of readily available natural products to other value-added secondary metabolites. However, the development of a chemical method that can be universally applied to structurally diverse natural products is nontrivial. Key to the successful reorganization of complex molecules is a versatil
We completed the synthesis of dimeric high-oxidation-state securinega alkaloid flueggeacosine B via two synthetic routes from allosecurinine. The first-generation synthesis (seven overall steps) involved a Liebeskind-Srogl cross-coupling reaction for the union of two functionalized fragments, the organostannane and the thioester. As a means to further streamline the synthetic route, we have developed a visible-light-mediated Cu-catalyzed cross-dehydrogenative coupling (CDC) reaction between an a
STING, a central protein in the innate immune response to cytosolic DNA, has emerged as a hot target for the development of vaccine-adjuvants and anticancer drugs. The discovery of potent human-STING (hSTING) agonist is expected to revolutionize the current cancer immunotherapy. Inspired by the X-ray crystal structure of DMXAA (5,6-dimethylxanthenone-4-acetic acid) and hSTINGG230I complex, we designed various DMXAA derivatives that contain a hydrogen bonding donor/acceptor or a halide at the C7
<i>Securinega</i> alkaloids, composed of more than 100 members characterized by the compact tetracyclic scaffold, have fascinated the synthetic community with their structural diversity and notable bioactivities. On the basis of the structural phenotype, oligomerizations and oxidations are major biosynthetic diversification modes of the basic <i>Securinega</i> framework. Despite the rich history of synthesis of basic monomeric <i>Securinega</i> alkaloids, the synthesis of oligomeric <i>Securineg
We present an ac-coupled scheme for burst-mode optical receivers optimized for 8B/10B line code. The cutoff frequencies of the ac-coupled circuits are carefully adjusted to achieve fast response with minimal distortion to the 8B/10B signal spectrum. The proposed scheme is simple and technically feasible due to its adaptability to well-established continuous-mode components. The burst-mode penalty of the ac-coupled receiver is also investigated using numerical analysis. The numerical results are
The isolation of flueggenines A and B by Yue and co-workers in 2006 has triggered a burst of isolation reports of dimeric and oligomeric securinega alkaloid natural products. The compelling molecular structures of these compounds with various modes of connection between monomeric securinega units have posed intriguing challenges to the synthetic organic community. Herein, we have categorized high-order securinega alkaloids based on their biosynthetic mode of dimerization or oligomerization. We t
We report the X-ray crystal structure of a site-selective peptide catalyst moiety and teicoplanin A2-2 complex. The expressed protein ligation technique was used to couple T4 lysozyme (T4L) and a synthetic peptide catalyst responsible for the selective phosphorylation of the N-acetylglucosamine sugar in a teicoplanin A2-2 derivative. The T4L-Pmh-dPro-Aib-dAla-dAla construct was crystallized in the presence of teicoplanin A2-2. The resulting 2.3 Å resolution protein-peptide-teicoplanin complex cr
Abstract Securinega alkaloids have fascinated the chemical community for over six decades. Among these intriguing secondary metabolites, there are members that are biosynthesized via oxidation(s) of the basic tetracyclic core of securinega natural products. These oxidation processes result in a sub‐family of natural products with intriguing structural variations. We have grouped them as “high‐oxidation state” securinega alkaloids. In this minireview, we, for the first time, categorize high‐oxida
We describe the total synthesis of (-)-flueggenines D and I. This features the first total synthesis of dimeric <i>Securinega</i> alkaloids with a C(α)-C(δ') connectivity between two monomeric units. The key dimerization was enabled by a sequence that involves Stille reaction and conjugate reduction. The high chemofidelity of the Stille reaction enabled us to assemble two structurally complex fragments that could not be connected by other methods. Stereochemical flexibility and controllability a
Post-iboga alkaloids are secondary metabolites that are biosynthetically derived from iboga-type alkaloids via rearrangements of the indole and/or isoquinuclidine moieties. Herein, we categorize post-iboga alkaloids into five types based on the biosynthetic mode of transformation of the iboga scaffold. We then describe reported syntheses of post-iboga alkaloids, including our laboratory’s recent contributions, based on our own categorization. 1 Introduction 1.1 Iboga and Post-Iboga Alkaloids 1.2
Since the first isolation of pseurotin A in 1976, over twenty five spirocyclic PKS-NRPS-based (polyketide synthase-nonribosomal peptide synthetase-based) fungal natural products have been discovered to date. The common 1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione core of this family of natural products has served as a platform for the development of novel chemistry and resulted in the development of numerous new reactivities and synthetic strategies. Herein, we delineate all reported syntheses of sp